Internal Medicine, Infectious Disease · Amityville, NY
NPI
1881601052
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
333 Broadway
Amityville, NY, 11701
Phone (631) 789-2020
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
22,333 services
Medicare patients, 2024
1,440
Average age 81
Drug cost, 2024
$2.1M
27,256 prescriptions
Company payments, 2025
$122
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohammud Alam was code 99308 (snf e&m), 20,384 times for 1,079 patients. In total Mohammud Alam billed 22,333 services in 25 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-02-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Facility | 20,384 | 1,079 | $60.96 | $1.2M |
| 99305 SNF E&M | Facility | 522 | 467 | $109.63 | $57K |
| 99349 Home E&M - New and Established | Office | 403 | 137 | $99.69 | $40K |
| 99348 Home E&M - New and Established | Office | 348 | 90 | $63.26 | $22K |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 161 | 106 | $42.36 | $6,820 |
| 99306 SNF E&M | Facility | 154 | 123 | $144.91 | $22K |
| 99315 SNF E&M | Facility | 92 | 87 | $67.33 | $6,195 |
| 99347 Home E&M - New and Established | Office | 87 | 60 | $37.60 | $3,271 |
| 99214 Office E&M - Established | Office | 73 | 31 | $94.73 | $6,915 |
| 99309 SNF E&M | Facility | 36 | 27 | $89.81 | $3,233 |
| 99345 Home E&M - New and Established | Office | 25 | 25 | $167.65 | $4,191 |
| 36415 Venipuncture Blood Collection | Office | 15 | 11 | $8.65 | $130 |
By year: 2022 $1.6M for 23,146 services; 2023 $1.8M for 25,433 services; 2024 $1.4M for 22,333 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 15 | 11 | $8.65 | $130 |
Medicare prescription drug claims, 2024
In 2024, the drug Mohammud Alam prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,249 prescriptions and refills. In total Mohammud Alam wrote 27,256 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,249 | 1,397 | 302 | $14K |
| Eliquis Apixaban | 1,017 | 1,047 | 161 | $415K |
| Amlodipine Besylate Generic | 975 | 1,111 | 210 | $7,333 |
| Levothyroxine Sodium Generic | 913 | 955 | 181 | $9,666 |
| Furosemide Generic | 807 | 827 | 184 | $5,061 |
| Potassium Chloride Generic | 788 | 808 | 129 | $15K |
| Metoprolol Tartrate Generic | 687 | 715 | 135 | $5,512 |
| Gabapentin Generic | 639 | 701 | 167 | $12K |
| Metoprolol Succinate Generic | 583 | 660 | 153 | $9,914 |
| Losartan Potassium Generic | 540 | 612 | 141 | $5,663 |
| Escitalopram Oxalate Generic | 505 | 533 | 110 | $6,871 |
| Sertraline Hcl Generic | 504 | 516 | 74 | $5,029 |
| Mirtazapine Generic | 475 | 483 | 115 | $13K |
| Omeprazole Generic | 447 | 485 | 122 | $5,185 |
| Donepezil Hcl Generic | 419 | 435 | 80 | $5,995 |
Brand drugs: 4,630 claims; generic drugs: 22,518 claims; opioid claims: 321.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohammud Alam $122 ($122 in general payments such as food, travel and fees) from 1 company. The largest payer was Otsuka America Pharmaceutical, Inc. with $122.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $122 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.